Nemaura Medical (NASDAQ:NMRD) is a medical technology company which has developed SugarBEATÂŽ as a CE Marked non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and pre-diabetics to better manage their glucose levels by spending more time in range. Insulin users can adjunctively use SugarBEATÂŽ when calibrated with a finger-stick glucose reading. SugarBEATÂŽ consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings at five-minute intervals for periods of up to 24 hours.
Source
